Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Schuind

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
Advances in Therapy|July 12, 2018
Enhanced Safety Surveillance of Seasonal Quadrivalent Influenza Vaccines in English Primary Care: Interim AnalysisSimon de Lusignan, Gaël Dos Santos, Rachel Byford, et al.
Influenza and Other Respiratory Viruses|September 5, 2020
Non-neutralizing antibody responses following A(H1N1)pdm09 influenza vaccination with or without AS03 adjuvant systemDamien Friel, Mary Co, Thierry Ollinger, et al.
Human Vaccines & Immunotherapeutics|January 17, 2019
Enhanced passive surveillance of influenza vaccination in England, 2016-2017- an observational study using an adverse events reporting cardSimon de Lusignan, Filipa Ferreira, Silvia Damaso, et al.
The Journal of Infectious Diseases|September 10, 2016
Immunogenicity and Safety of an AS03-Adjuvanted H7N9 Pandemic Influenza Vaccine in a Randomized Trial in Healthy AdultsAnuradha Madan, Nathan Segall, Murdo Ferguson, et al.
Vaccine|March 18, 2017
Immunogenicity and safety of an AS03-adjuvanted H7N1 vaccine in adults 65years of age and older: A phase II, observer-blind, randomized, controlled trialAnuradha Madan, Murdo Ferguson, Paul Rheault, et al.
Vaccine|July 20, 2017
Evaluation of a primary course of H9N2 vaccine with or without AS03 adjuvant in adults: A phase I/II randomized trialAnuradha Madan, Harry Collins, Eric Sheldon, et al.
Pain|September 6, 2022
Adjuvanted recombinant zoster vaccine decreases herpes zoster-associated pain and the use of pain medication across 3 randomized, placebo-controlled trialsJoon Hyung Kim, Robert Johnson, Martina Kovac, et al.
Human Vaccines & Immunotherapeutics|March 3, 2020
Brand-specific enhanced safety surveillance of GSK's Fluarix Tetra seasonal influenza vaccine in England: 2017/2018 seasonSimon de Lusignan, Silvia Damaso, Filipa Ferreira, et al.
Vaccine|October 9, 2017
Immunogenicity and safety of an inactivated quadrivalent influenza vaccine co-administered with a 23-valent pneumococcal polysaccharide vaccine versus separate administration, in adults ≥50years of age: Results from a phase III, randomized, non-inferiority trialOpokua Ofori-Anyinam, Geert Leroux-Roels, Mamadou Drame, et al.
Vaccine|June 6, 2007
Swelling at or near injection site: case definition and guidelines for collection, analysis and presentation of immunization safety dataKatrin S Kohl, Wikke Walop, Jane Gidudu, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Advances in Therapy|July 12, 2018
Enhanced Safety Surveillance of Seasonal Quadrivalent Influenza Vaccines in English Primary Care: Interim AnalysisSimon de Lusignan, Gaël Dos Santos, Rachel Byford, et al.
Influenza and Other Respiratory Viruses|September 5, 2020
Non-neutralizing antibody responses following A(H1N1)pdm09 influenza vaccination with or without AS03 adjuvant systemDamien Friel, Mary Co, Thierry Ollinger, et al.
Human Vaccines & Immunotherapeutics|January 17, 2019
Enhanced passive surveillance of influenza vaccination in England, 2016-2017- an observational study using an adverse events reporting cardSimon de Lusignan, Filipa Ferreira, Silvia Damaso, et al.
The Journal of Infectious Diseases|September 10, 2016
Immunogenicity and Safety of an AS03-Adjuvanted H7N9 Pandemic Influenza Vaccine in a Randomized Trial in Healthy AdultsAnuradha Madan, Nathan Segall, Murdo Ferguson, et al.
Vaccine|March 18, 2017
Immunogenicity and safety of an AS03-adjuvanted H7N1 vaccine in adults 65years of age and older: A phase II, observer-blind, randomized, controlled trialAnuradha Madan, Murdo Ferguson, Paul Rheault, et al.
Vaccine|July 20, 2017
Evaluation of a primary course of H9N2 vaccine with or without AS03 adjuvant in adults: A phase I/II randomized trialAnuradha Madan, Harry Collins, Eric Sheldon, et al.
Pain|September 6, 2022
Adjuvanted recombinant zoster vaccine decreases herpes zoster-associated pain and the use of pain medication across 3 randomized, placebo-controlled trialsJoon Hyung Kim, Robert Johnson, Martina Kovac, et al.
Human Vaccines & Immunotherapeutics|March 3, 2020
Brand-specific enhanced safety surveillance of GSK's Fluarix Tetra seasonal influenza vaccine in England: 2017/2018 seasonSimon de Lusignan, Silvia Damaso, Filipa Ferreira, et al.
Vaccine|October 9, 2017
Immunogenicity and safety of an inactivated quadrivalent influenza vaccine co-administered with a 23-valent pneumococcal polysaccharide vaccine versus separate administration, in adults ≥50years of age: Results from a phase III, randomized, non-inferiority trialOpokua Ofori-Anyinam, Geert Leroux-Roels, Mamadou Drame, et al.
Vaccine|June 6, 2007
Swelling at or near injection site: case definition and guidelines for collection, analysis and presentation of immunization safety dataKatrin S Kohl, Wikke Walop, Jane Gidudu, et al.
Pageof 6